“…For instance, postmortem profiles of several mRNA species, such as immediate early genes, hypoxia-inducible factor-1α, erythropoietin, vascular endothelial growth factor, glucose transporter-1, surfactants, and dual-specificity phosphatase 1, have been proposed to be related to certain causes and circumstances of death (Ikematsu et al, 2005;Miyazato et al, 2012;Takahashi et al, 2009;Zhao et al, 2006;. However, in contrast to the identification of body fluids and tissues using nucleic acid biomarkers (Courts and Madea, 2011;Haas et al, 2009;Juusola and Ballantyne, 2003;Zubakov et al, 2008;, the application of molecular pathological examination based on postmortem gene expression profiles to death processes appears to be still challenging. Despite technical advances in resolving the difficulties of sensitivity and standardization (Catts, 2005;Heinrich et al, 2007b;Lee et al, 2005), there remain limitations primarily due to the restricted understanding of molecular physiology at the time of death and, subsequently, the insufficiency of well-established forensic RNA biomarkers.…”